CloudVisit and I Do App Partner On New Telehealth Platform


Cold Springs, NY-based telehealth provider CloudVisit announces a partnership with I Do App, a home monitoring device manufacturer. The partnership will bring the two companies together to build an out-of-the-box solution marketed to private practices that want to begin offering telehealth visits supplemented with remote patient monitoring tools.

CloudVisit entered the telehealth market by offering HIPAA compliant website and video conferencing services to private practices that wanted to start offering remote telehelath and telepsychiatry sessions to their patients. The company offers tiered plans that range from $175 – $300 per month and delivers a white labeled website for patients and clinicians to log into and conduct telehealth visits on a secure platform.

In an effort to expand its home-based care model, CloudVisit is partnering with I Do App. I Do App makes connected home health tools, offering a similar product mix to Withings. I Do App markets a blood pressure monitor, an activity tracker, and a “body health analyzer” that is essentially a wireless scale. It measures weight, body fat, body mass index, muscle mass, bone mass, and body water. Information from the product line is pushed to a central mobile app, and now, through its new partnership, this information will also be integrated into the CloudVisit telehealth platform.

"With this partnership, we provide everything. Private-label devices for resale, mobile app for personal tracking, and HIPAA-compliant video appointments. Healthcare providers can become the complete fitness and wellness solution for their patients." – CloudVisit CEO Daniel Gilbert.

The press release focuses on bringing telehealth services to several key markets, including internal medicine, pediatrics, geriatrics, and chronic condition management. The partnership is interesting in that it integrates affordable connected devices with an equally affordable telehealth services, and then pushes this new platform into a relatively untapped market.

One noteworthy technical limitation of the platform is that I Do App’s devices cannot capture a full set of vitals. One would think that vitals would be the first health metrics that would be targeted when connecting a telehealth platform with a home monitoring device. If a patient owned the entire I Do App product line, the devices could capture height, weight, and blood pressure, but there is little else of clinical value that the devices would bring to the platform. 

Enjoy HIStalk Connect? Sign up for update alerts, or follow us at @HIStalkConnect.

↑ Back to top

Founding Sponsors

Platinum Sponsors